Quality of life of patients with inflammatory bowel diseases

Aim
The aim of this paper was to assess the quality of life of patients treated for inflammatory bowel diseases.

Material and methods
The study was conducted in a group of 103 people treated for inflammatory bowel diseases. The research was conducted from November 2021 to January 2022 after obtaining the consent of the Bioethics Committee. The research tool was the author's questionnaire, the modified Mayo scale and the SF-36 questionnaire for assessing the quality of life. The significance level of p<0.05 was adopted in the study.

Results
Patients' quality of life was reduced in the dimension of physical health. Patients treated for inflammatory bowel disease rated quality of life at an average level in the domains of physical functioning, social functioning and mental health. Quality of life was at a low level in the elderly, in women, in those with lower education and in residents of cities.The severity of symptoms affected the overall assessment of quality of life.

Conclusions
The overall quality of life of the patients was reduced. The level of acceptance of the disease and the quality of life of the respondents are influenced by socio-demographic factors and the clinical course of the disease. The severity of symptoms affected the overall assessment of quality of life. Health education of patients with inflammatory bowel diseases regarding the disease, self-care and skilful support in difficult situations is the basis for increasing the assessment of the quality of life and the level of acceptance of the disease.